WTR Biotech Spotlight
WTR Biotech Spotlight is a biweekly conversation with biotech executives, medical experts, and investors on recent clinical data or industry-driving events in biotech.
WTR Biotech Spotlight
Trevi Therapeutics CEO Jennifer Good Discusses Oral Haduvio Benefit in Chronic Cough
•
Joe Brunetto
•
Season 1
•
Episode 12
Trevi Therapeutics CEO Jennifer Good joins us on this week’s WTR Biotech Spotlight to talk about the recent and impressive clinical data for Haduvio in IPF-associated chronic cough and refractory chronic cough. We discuss Haduvio’s unique mechanism and unscheduled status, supported by a human abuse study. Listen to learn more about Trevi Therapeutics and how Haduvio could change the chronic cough treatment landscape.